Get the Stockscreener App
4.36
3.32%
0.14
After Hours:
4.36
Eledon Pharmaceuticals Inc Stock (ELDN) Forecast
The Eledon Pharmaceuticals Inc (ELDN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $2.7251, representing a -37.50% decrease from the current price of $4.36. The highest analyst price target is $2.6507, and the lowest is $2.7995.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ELDN Price Target
Average 4.1161
(-5.59% Downside)
Is Eledon Pharmaceuticals Inc (ELDN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 50.51 | Neutral |
| STOCH(9,6) | 26.67 | Neutral |
| STOCHRSI(14) | 25.77 | Neutral |
| MACD(12,26) | 0.0603 | Sell |
| ADX(14) | 18.42 | Neutral |
| William %R | -63.72 | Neutral |
| CCI(14) | -71.13 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.485
Sell
|
4.3998
Sell
|
| MA20 |
4.4403
Sell
|
4.3928
Sell
|
| MA50 |
4.1234
Buy
|
4.0802
Buy
|
| MA100 |
3.3888
Buy
|
3.6155
Buy
|
| MA200 |
2.8783
Buy
|
3.0269
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ELDN could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on ELDN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 50.51 indicates that ELDN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 26.67 indicates that ELDN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 25.77 indicates that ELDN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 18.42 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -71.13 indicates that ELDN is still oversold but not to an extreme extent.
Long-term ELDN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Eledon Pharmaceuticals Inc financial reports and earnings history, Eledon Pharmaceuticals Inc (ELDN) stock could reach $11.19 by 2030, $46.50 by 2040 and $24.20 by 2050. See the projected annual prices until 2050 of the Eledon Pharmaceuticals Inc stock below:
- Eledon Pharmaceuticals Inc (ELDN) is expected to reach an average price of $9.1049 in 2035, with a high prediction of $9.3053 and a low estimate of $9.1749. This indicates an $108.83% rise from the last recorded price of $4.36.
- Eledon Pharmaceuticals Inc (ELDN) stock is projected to chart a bullish course in 2040, with an average price target of $44.69, representing an $924.94% surge from its current level. The forecast ranges from a conservative $44.84 to a sky-high $46.50.
- Our analysts predict Eledon Pharmaceuticals Inc (ELDN) to jump 808.21% by 2045, soaring from $39.62 to an average price of $39.60, potentially reaching $39.35. While $39.62 is the low estimate, the potential upside is significant.
- Eledon Pharmaceuticals Inc (ELDN) stock is expected to climb by 2050, reaching an average of $23.59, a $440.96% jump from its current level. However, a wide range of estimates exists, with high and low targets of $24.20 and $23.68, respectively, highlighting the market's uncertainty.
Eledon Pharmaceuticals Inc Stock (ELDN) Year by Year Forecast
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2025
Eledon Pharmaceuticals Inc Stock (ELDN) is expected to reach an average price of $4.1161 in 2025, with a high prediction of $5.4328 and a low estimate of $2.7995. This indicates an -5.59% fall from the last recorded price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $3.3707 | $2.7995 | $2.6507 | -22.69% |
| February, 2025 | $4.1821 | $3.7573 | $3.8471 | -4.08% |
| March, 2025 | $4.9735 | $4.7537 | $4.8769 | +14.07% |
| April, 2025 | $5.6564 | $4.5667 | $4.5964 | +29.74% |
| May, 2025 | $5.0528 | $5.1562 | $4.7766 | +15.89% |
| June, 2025 | $5.4492 | $5.3594 | $5.3992 | +24.98% |
| July, 2025 | $5.1422 | $5.0056 | $5.0724 | +17.94% |
| August, 2025 | $5.3986 | $5.3988 | $5.3108 | +23.82% |
| September, 2025 | $5.045 | $4.6484 | $4.7352 | +15.71% |
| October, 2025 | $5.6371 | $5.4816 | $5.4328 | +29.29% |
| November, 2025 | $4.8044 | $5.0217 | $4.9846 | +10.19% |
| December, 2025 | $5.3573 | $5.071 | $5.2773 | +22.87% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2026
The predicted value for Eledon Pharmaceuticals Inc (ELDN) in 2026 is set at an average of $3.6956. Estimates vary from a peak of $4.6039 to a trough of $2.7872, indicating an -15.24% surge from the present price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.5837 | $4.8887 | $4.6039 | +5.13% |
| February, 2026 | $3.6701 | $4.2335 | $4.2903 | -15.82% |
| March, 2026 | $3.7665 | $3.7067 | $3.4465 | -13.61% |
| April, 2026 | $4.5245 | $4.4097 | $4.2379 | +3.77% |
| May, 2026 | $4.1559 | $4.3559 | $4.3477 | -4.68% |
| June, 2026 | $3.9623 | $4.0523 | $3.9791 | -9.12% |
| July, 2026 | $3.3053 | $3.9921 | $3.8252 | -24.19% |
| August, 2026 | $2.6716 | $2.8043 | $3.1619 | -38.72% |
| September, 2026 | $3.3646 | $3.0182 | $3.3056 | -22.83% |
| October, 2026 | $3.151 | $3.3712 | $3.2012 | -27.73% |
| November, 2026 | $2.6474 | $3.2374 | $3.0042 | -39.28% |
| December, 2026 | $3.1814 | $2.7872 | $2.7304 | -27.03% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Eledon Pharmaceuticals Inc (ELDN) is $1.7634, with a high forecast of $3.20 and a low forecast of $0.3268. This indicates an -59.55% decrease from the last price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.2468 | $3.0336 | $2.8768 | -25.53% |
| February, 2027 | $3.1632 | $3.2832 | $3.20 | -27.45% |
| March, 2027 | $3.1061 | $3.1396 | $3.0483 | -28.76% |
| April, 2027 | $2.7125 | $2.7125 | $2.8527 | -37.79% |
| May, 2027 | $2.5389 | $2.7089 | $2.6623 | -41.77% |
| June, 2027 | $2.0819 | $2.1519 | $2.1722 | -52.25% |
| July, 2027 | $2.2483 | $2.3183 | $2.2351 | -48.43% |
| August, 2027 | $1.6947 | $1.9747 | $2.1615 | -61.13% |
| September, 2027 | $1.2777 | $1.2945 | $1.5613 | -70.70% |
| October, 2027 | $0.9441 | $1.0841 | $0.9443 | -78.35% |
| November, 2027 | $0.9104 | $0.7739 | $0.7173 | -79.12% |
| December, 2027 | $0.5334 | $0.3268 | $0.6885 | -87.77% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2028
In 2028, Eledon Pharmaceuticals Inc (ELDN) is projected to reach an average price of $7.442, with a high projection of $14.87 and a low estimate of $0.0103. This indicates an +70.69% rise from the last price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.3502 | $0.0103 | $0.43 | -91.97% |
| February, 2028 | $9.7564 | $0.1397 | $9.276 | +123.77% |
| March, 2028 | $10.15 | $6.836 | $7.9597 | +132.85% |
| April, 2028 | $12.93 | $10.84 | $12.13 | +196.45% |
| May, 2028 | $13.09 | $12.67 | $11.96 | +200.25% |
| June, 2028 | $13.14 | $13.92 | $13.17 | +201.47% |
| July, 2028 | $14.35 | $13.67 | $14.16 | +229.05% |
| August, 2028 | $15.15 | $14.40 | $14.34 | +247.54% |
| September, 2028 | $14.78 | $15.22 | $14.85 | +238.89% |
| October, 2028 | $13.18 | $13.25 | $13.00 | +202.25% |
| November, 2028 | $14.34 | $14.07 | $14.05 | +228.88% |
| December, 2028 | $14.92 | $14.86 | $14.87 | +242.13% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2029
The 2029 price forecast for Eledon Pharmaceuticals Inc Stock (ELDN) is $12.80 on average, with a high prediction of $14.65 and a low estimate of $10.96. This represents an +193.67% increase from the previous price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $15.33 | $14.40 | $14.27 | +251.67% |
| February, 2029 | $14.52 | $14.67 | $14.35 | +232.93% |
| March, 2029 | $14.70 | $14.77 | $14.65 | +237.12% |
| April, 2029 | $13.82 | $14.04 | $14.24 | +217.00% |
| May, 2029 | $14.17 | $14.33 | $14.13 | +224.94% |
| June, 2029 | $13.60 | $13.26 | $13.45 | +211.93% |
| July, 2029 | $13.85 | $13.98 | $13.64 | +217.72% |
| August, 2029 | $12.88 | $13.10 | $13.72 | +195.38% |
| September, 2029 | $13.28 | $13.09 | $12.94 | +204.62% |
| October, 2029 | $12.18 | $12.48 | $13.08 | +179.30% |
| November, 2029 | $11.05 | $11.67 | $11.83 | +153.45% |
| December, 2029 | $10.93 | $10.96 | $10.75 | +150.76% |
Eledon Pharmaceuticals Inc Stock (ELDN) Price Forecast for 2030
Eledon Pharmaceuticals Inc Stock (ELDN) is expected to reach an average price of $9.3599 in 2030, with a high forecast of $11.19 and a low forecast of $7.5291. This signifies an +114.68% surge from the last price of $4.36.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $11.42 | $11.42 | $11.19 | +162.02% |
| February, 2030 | $10.84 | $11.04 | $11.14 | +148.66% |
| March, 2030 | $10.43 | $10.52 | $10.56 | +139.32% |
| April, 2030 | $10.24 | $10.30 | $10.22 | +134.80% |
| May, 2030 | $8.6633 | $8.8494 | $9.5105 | +98.70% |
| June, 2030 | $9.2461 | $8.9565 | $8.9061 | +112.07% |
| July, 2030 | $8.662 | $9.0424 | $9.0303 | +98.67% |
| August, 2030 | $7.9448 | $8.5348 | $8.4084 | +82.22% |
| September, 2030 | $7.8676 | $7.9244 | $7.878 | +80.45% |
| October, 2030 | $8.0636 | $7.9572 | $7.7736 | +84.94% |
| November, 2030 | $7.7663 | $7.8863 | $7.9099 | +78.13% |
| December, 2030 | $7.4901 | $7.5291 | $7.598 | +71.79% |
2.88%
2.65%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):